Author

S. del Rincon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:multiome· 1

Frequent Co-Authors

A. Benoit· 1 shared A. Chaudhury· 1 shared A. Emond· 1 shared A. Galan· 1 shared C. A. Piccirillo· 1 shared C. Goncalves· 1 shared D. Dankort· 1 shared D. Plourde· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Benoit

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The MNK1/2-eIF4E axis contributes to phenotype switching, melanoma progression, and resistance to immunotherapy.

F. Huang, C. Goncalves, M. Bartish, J. Remy-Sarrazin, Q. Guo, A. Emond, W. Yang, D. Plourde, J. Su, M. G. Gimeno, Y. Zhan, M. Attias, A. Galan, T. rzymski, M. Mazan, , S. del Rincon

This study identifies the MNK1/2-eIF4E axis as a driver of melanoma phenotype switching, progression, and immunotherapy resistance, with potential therapeutic targeting.

bioRxiv · May 29, 2020Cancer Biology

CELF1 is an EIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAs

A. Chaudhury, R. Pal, N. Kongchan, N. Zhao, Y. Zhu, E. Olokpa, S. Cheema, S. del Rincon, L. C. Reineke, S. Mao, R. E. Llyod, M. Sardiello, J. M. Rosen, J. R. Neilson

The paper shows CELF1 binds eIF4E and PABP to promote translation of EMT effector mRNAs, and disrupting this interaction inhibits EMT and metastasis.

bioRxiv · May 16, 2019 · PreprintCancer Biology